Neurofibrillary tangles and senile plaques are the principal pathological features of Alzheimer disease. Neurofibrillary tangles and the neurites of senile plaques contain paired helical filaments (PHF) that consist of two 10-nm filaments twisted into a double helix. The precursor proteins of PHIF are not fully known. To identify these precursors, numerous immunochemical studies have been carried out during the past decade. Two apparently conflicting results have been reported. (I) Some, but not all, monoclonal antibodies to neuroframents stained neurofibrillary tangles. (is) Polyclonal antibodies prepared to PHF purified in NaDodSO4 because of their unusual insolubility did not recognize normal proteins, including neurofilaments, on electrophoretic transfer blots of human brain homogenates. These results have been confirmed in several laboratories, including by the use of electron microscopic labeling. Recently, we reported that polyconal PHF antibodies include antibodies to tau proteins, a family of heat-stable microtubule-associated phosphoproteins, and that antibodies to tau stain Alzheimer neurofibrillary tangles. Those monoclonal neuroframent antibodies that recognize tangles are reported to be directed against phosphorylated epitopes. These facts prompted us to reexamine certain neurofilament monoclonal antibodies that stain neurofibrillary tangles. All monoclonal neurofflament antibodies that stain tangles that we examined, including those initially reported, reacted with tau proteins. Our results suggest that these antibodies react with phosphorylated tau proteins in PH1F, not neurofilament proteins, highlighting the problem of using antibodies to phosphorylated protein epitopes in immunochemical studies. Independent evidence for the presence of neurofflament proteins in human paired helical filaments is now required.
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One of the major neuropathological changes occurring in human neurons during aging and in Alzheimer disease is the neurofibrillary tangle. Tangles are made of masses of paired helical filaments (PHF), each member of which has a diameter of about 10 nm (1) . The dystrophic cortical neurites comprising senile plaques in Alzheimer disease and human brain aging also contain PHF. The precursor proteins of PHF have been searched for intensively using immunocytochemical methods. These studies have produced three principal findings. (i) Tangles are stained by polyclonal antibodies to microtubule fractions (2, 3) and by polyclonal and monoclonal antibodies to microtubule-associated protein 2 (MAP2) (4, 5) . (ii) Antibodies to neurofilament proteins, particularly the Mr 200,000 and Mr 160,000 components, stain tangles (6) (7) (8) (9) . (iii) Antibodies to partially purified PHF fractions extracted in NaDodSO4 react with no specific proteins in human brain homogenates, including neurofilament proteins, and produce a peculiar smear of immunoreactivity on electrophoretic transfer blots of Alzheimer disease brain homogenates (10).
However, it has been found that all of several antisera to PHF include antibodies to the MAPs designated tau when MAP fractions highly enriched in tau are examined (11) (12) (13) . These antibodies to PHF include antibodies specifically directed at the phosphorylated forms of tau (14) . Furthermore, a monoclonal tau antibody, Tau-1, stains tangles, and the number of tangles it recognizes is markedly increased by dephosphorylation of brain sections (15, 16) . The monoclonal neurofilament antibodies that recognize tangles are also reported to be against phosphorylated epitopes (17, 18) . These results prompted us to recharacterize certain monoclonal neurofilament antibodies previously shown to recognize tangles.
MATERIALS AND METHODS
Biochemical reagents, Escherichia coli alkaline phosphatase (types Il-N and III-R), pepstatin, leupeptin, and phenylmethylsulfonyl fluoride were products of Sigma.
Antibodies. Monoclonal antibodies RT97, BF10, 8D8, and 1215 were produced and kindly provided (as ascites fluids) by B. Anderton and colleagues, who showed that they stain the Mr 200,000 and Mr 160,000 neurofilament proteins as well as neurofibrillary tangles (7, 9) . Monoclonal antibodies 147 and RS18, also provided as ascites fluids by Anderton and colleagues, stain neurofilaments but not tangles (9) . Two monoclonal antibodies to the neurofilament Mr 200,000 and Mr 160,000 polypeptides (here designated BM200 and BM160, respectively) were obtained as purified IgG (20 ,g/ml) from Boehringer Mannheim. SMI31 and SMI34 were purchased from Sternberger-Meyer (Jarrettsville, MD) as ascites fluids. The former is marketed as an antibody to phosphorylated neurofilament protein and the latter is marketed as an antibody to neurofilaments that stains Alzheimer neurofibrillary tangles. Polyclonal antibodies to PHF were obtained as reported (10) . A monoclonal antibody to tau, 5E2, was raised in this laboratory and used as a hybridoma supernatant. A monoclonal antibody to MAP2, SF9, that stains tangles has been reported (5) and was used as a supernatant. Affinity-purified antibodies specific to phosphorylated tau that were prepared from a PHF antiserum as described (14) were the gift of Y. Ihara.
Microtubule and Neurofilament Preparations. Microtubules were prepared from rat brains using the assembly/disassembly method of Shelanski et al. (19 with E. coli alkaline phosphatase (type I1-N), 10 units/ml, with protease inhibitors (leupeptin at 10 ug/ml, pepstatin at 10 ,ug/ml, and 1 mM phenylmethylsulfonyl fluoride) for 18 hr at 370C.
Electrophoresis and Immunoblotting. Ten percent NaDod-S04/polyacrylamide gel electrophoresis (NaDodSO4/ PAGE) was performed according to Laemmli (20) . Immunoblot studies were performed according to Towbin et al. (21) . Blots were incubated with each antibody for 2 hr at room temperature or overnight at 40C. Blots were stained by the avidin-biotin complex method (Vectastain ABC kit; Vector Laboratories, Burlingame, CA). The reactivities of monoclonal antibodies with phosphorylated and dephosphorylated forms of rat MAPs and rat neurofilament proteins (except for BF10, which was reacted with human neurofilaments) were determined according to Lee et al. (22) or by the method of Stemberger and Sternberger (23) . Antibody dilutions are provided in the figure legends.
Tangle Reactivity. Tangle staining was determined by reactivity of the antibodies with in situ tangles in formalinfixed brain sections as well as with tangles isolated from frozen cerebral cortex in Tris/saline. All antibodies were used at the same dilutions as on immunoblots. Incubations in primary antibodies were for 2 hr at room temperature or overnight at 40C, as used for the blots.
RESULTS
Immunoblots of heat-stable MAPs stained with each antibody are shown in Fig. 1 . The tau proteins consist of six or seven bands in their phosphorylated form. When the MAP fraction was treated with alkaline phosphatase, a modest increase in electrophoretic mobility of tau proteins appeared, as reported by Lindwall and Cole (24) . Antisera to PHF and the tau monoclonal antibody 5E2 stained phosphorylated and dephosphorylated forms of tau. Six different neurofilament monoclonal antibodies, 8D8, RT97, 1215, BF10, SMI31, and SMI34, all reacted with phosphorylated but not dephosphorylated tau proteins (Fig. 1) . Similar results were obtained with affinity-purified antiphosphorylated tau antibodies prepared from a PHF antiserum (Fig. 1, lane 1) . However, the staining intensity of each of the tau bands varied among the various antibodies examined. All ofthese antibodies stained neurofibrillary tangles (see, for example, Fig. 2 ). These antibodies also stained the gel excluded, insoluble material of heat-stable MAP fractions, suggesting that some portion of tau proteins is aggregated under the conditions of NaDodSO4/PAGE (Fig. 1) . Neurofilament antibodies 1215 and SMI31 also reacted with MAP2; dephosphorylation abolished the reactivity with MAP2 of SMI31 but not of 1215 (Fig. 2) . The other neurofilament antibodies tested (147, RS18, BM200, and BM160) did not react with any proteins in the heat-stable MAP preparation except for weak staining of a Mr 200,000 band by 147 (Fig. 2 ). This band is sometimes weakly stained by other neurofilament antibodies and seems to be the neurofflament Mr 200,000 polypeptide. All neurofilament antibodies reacted with phosphorylated but not dephosphorylated neurofilament proteins, thus mimicking their reactivity on tau proteins (data not shown). An anti-MAP2, SF9, reacted strongly with MAP2 and its degraded products, and dephosphorylation had no effect on this reaction (Fig. 1, lane 8) . SF9 seemed to stain bands in the tau region ofthe blot very weakly but we could not be certain that these were tau since, at higher dilutions, such staining was not seen and breakdown products of MAP2 in the Mr 50,000-60,000 region could be the source of these reactive bands. The characterization of all antibodies is summarized in Table 1 .
The effect of dephosphorylation on the staining of neurofibrillary tangles was determined using SMI31, RT97, and anti-PHF. Prior to dephosphorylation, all three antibodies stain Alzheimer neurofibrillary tangles that we examined react with tau and sometimes also react with MAP2 to varying degrees. (it) All of these tangle-reactive antibodies react exclusively with the phosphorylated forms of the neurofilament and tau proteins. SMI31, an antibody to phosphorylated neurofilaments that was not previously reported to stain tangles, also reacted with tau. We, therefore, checked its reactivity on tangles and found that it, too, labeled tangles (Fig. 2) . These results indicate that those neurofilament monoclonal antibodies that crossreact with phosphorylated epitopes of tau recognize neurofibrillary tangles. In further experiments, we have found that polyclonal anti-chicken neurofilament antibodies (25) and polyclonal anti-rat Mr 200,000 neurofilament antibodies (6) that have been shown to stain tangles also react with phosphorylated and dephosphorylated tau. SMI32 and SM133 (SternbergerMeyer) that react with phosphorylated and dephosphorylated neurofilament Mr 200,000 protein do not label tangles or tau proteins (data not shown).
Our study suggests that neurofflament Mr 200,000 and Mr 160,000 proteins, tau and MAP2, all have conformational or sequential similarities around phosphorylation sites and that these shared sites are recognized by the various neurofilament antibodies.
Altered Forns of Tau Are Present in P1F. Recently, we reported that polyclonal antibodies to PHF include antibodies to tau and, in particular, to phosphorylated tau (12) (13) (14) . Antibodies to native tau also stain Alzheimer neurofibrillary tangles (13) . In this study, we have shown that a monoclonal tau antibody, 5E2, that stains tangles recognizes phosphorylated and dephosphorylated tau. Similarly, polyclonal PHF antibodies that were raised against NaDodSO4-isolated PHF we have no independent evidence for the existence of neurofilament components in PHF. To propose this possibility, it must now be demonstrated that PHF contain amino acid sequences or specific immunoreactive sites (other than phosphorylated epitopes) deriving solely from neurofilaments. In the light of the data reported here, the notion of an aberrant phosphorylation of neurofilaments in Alzheimer disease (17) requires reconsideration. Our report may clarify somewhat the controversy about the nature of the principal antigenic components of PHF. Every antibody that was previously reported to react with PHF [antibodies to PHF (11) (12) (13) , antibodies to microtubule fractions (30) , and antibodies to neurofilament proteins] recognizes tau. Phosphorylated epitopes on several cytoskeletal proteins thus seem to crossreact (31) . These results indicate the need for caution when using antibodies to decipher the composition of abnormal cytoskeletal proteins. 
